Analysis – Page 21 – Goldea Capital

LPL Financial Welcomes Zarra Wealth Management

Written by Customer Service on August 19, 2025. Posted in Public Companies.

SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the advisors of Zarra Wealth Management have joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) platform. They reported serving approximately $270 million in advisory, brokerage and retirement plan assets* and join LPL from Ameriprise. Based on Long Island, in Westbury, NY, the team consists of Christopher Zarra, CFP®, CHFC®, CFS®, James Kelly CFP®, APMA™ and Michele Welch, CFP®. They bring 48 years of collective financial industry experience focusing on families, pre-retiree and retiree clients. The team in particular prides itself on achieving the rigorous CFP® designation and providing the utmost in fiduciary guidance to their clients. “We’re often introduced to our clients’ family members because of the high-touch,...

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

Written by Customer Service on August 19, 2025. Posted in Public Companies.

90-day trial measuring change in general fatigue in chronic babesiosis patients Enrollment expected to commence Q4 2025 and to be completed by Q2 2026 Site has clinical expertise in infectious disease trials and access to a robust patient population with tick-borne illness, including chronic babesiosis No FDA-approved treatment exists for chronic babesiosis, a debilitating illnessWASHINGTON, Aug. 19, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced today it has signed a clinical trial agreement with the Icahn School of Medicine at Mount Sinai in New York City as the central site for a Phase II clinical study of tafenoquine in treating chronic babesiosis. For the...

La Rosa Holdings Corp. Reports 27% Year-Over-Year Increase in Revenue to $40.7 Million for First Half of 2025 as Compared to First Half of 2024

Written by Customer Service on August 19, 2025. Posted in Earnings Releases And Operating Results.

Q2 2025 Revenue Increased 22% Year-Over Year to $23.2 Million as Compared to Q2 2024 CELEBRATION, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today provided a business update and reported financial results for the for the second quarter ended June 30, 2025. Q2 2025 Financial HighlightsTotal revenue increased 22% year-over-year to $23.2 million for the second quarter ended June 30, 2025 from $19.1 million for the second quarter ended June 30, 2024. Residential real estate services revenue increased by approximately $3.9 million to $19.7 million, or 24%, for the second quarter ended June 30, 2025 from $15.9 million for the second quarter ended June 30, 2024 Property management revenue increased by approximately $326 thousand to approximately...

Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights

Written by Customer Service on August 19, 2025. Posted in Earnings Releases And Operating Results.

Submitted New Drug Application (NDA) to the FDA for lead asset CTx-1301Anticipate FDA Decision in Q4 2025 regarding NDA Acceptance with Potential PDUFA Date in Mid-2026 KANSAS CITY, Kan., Aug. 19, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced its financial results for the quarter ended June 30, 2025, and provided recent highlights. Recent Highlights: On July 31, 2025, Cingulate submitted its NDA to the FDA for CTx-1301, a novel, extended-release tablet formulation of dexmethylphenidate designed to deliver a fast onset, entire active-day efficacy, and a smooth pharmacokinetic profile with a single...

TowneBank Expands Carolinas Presence Through Agreement to Acquire Dogwood State Bank

Written by Customer Service on August 19, 2025. Posted in Mergers And Acquisitions.

SUFFOLK, Va. and RALEIGH, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) — Hampton Roads based TowneBank (NASDAQ: TOWN) and Raleigh based Dogwood State Bank (OTCQX: DSBX) (“Dogwood”), today announced the signing of a definitive merger agreement pursuant to which TowneBank will acquire Dogwood State Bank. The proposed transaction substantially enhances TowneBank’s strategic journey down the fast-growing Interstate 85 corridor from Richmond, Virginia to Greenville and the upstate region of South Carolina. The bank’s current market position will be expanded in Raleigh, Greensboro-Winston Salem, Greenville, and Charlotte, North Carolina. Additionally, the merger will increase the bank’s footprint along the Eastern North Carolina coast from the Outer Banks to also include Morehead City, Greenville, Fayetteville, and Wilmington along with a new...

LEEF Brands Reports Second Quarter 2025 Financial Results

Written by Customer Service on August 19, 2025. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) — LEEF Brands, Inc. (CSE: LEEF, OTC: LEEEF) (“LEEF” or the “Company”), a premier California and New York cannabis operator, today announced its financial and operating results for the second quarter ended June 30, 2025. All figures are reported in U.S. dollars unless otherwise indicated. Q2 2025 Financial Highlights:Revenue: $8.7 million, up 10% from $7.9 million in Q2 2024, driven by a 19% year-over-year increase in unit sales. Gross Margin: 24%, compared to 34% in Q2 2024, reflecting higher input costs for clean extraction material. Margins are expected to improve as the Company begins processing material from Salisbury Canyon Ranch in 3Q 2025. Net Loss: $2.9 million, or ($0.02) per share, a 45% improvement from a $5.5 million loss in Q2 2024. Adjusted...

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Written by Customer Service on August 19, 2025. Posted in Mergers And Acquisitions.

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid removal MINNEAPOLIS, Aug. 19, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on improving patient outcomes through advanced fluid management, today announced it has signed a non-binding letter of intent (LOI) to acquire Rendiatech, Ltd., an Israeli-based medical device company specializing in real-time urine flow and acute kidney injury monitoring technologies. The proposed acquisition is expected to support Nuwellis’ strategy to expand its current technology platform beyond ultrafiltration by potentially adding continuous renal health monitoring technologies...

VCI Global Announces US$2 Billion Partnership Secured by Sovereign-Grade Encrypted Infrastructure

Written by Customer Service on August 19, 2025. Posted in Public Companies.

Joint Venture Anchored by 18,000 BTC to Power Real-World Asset Tokenization, Encrypted Vault Monetization, and Institutional-Grade Crypto Infrastructure KUALA LUMPUR, Malaysia, Aug. 19, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a cross-sector platform builder integrating deep technology with financial architecture to enable sovereign-ready digital ecosystems, today announced a landmark partnership with a leading digital asset holder to establish a sovereign-grade infrastructure venture backed by 18,000 BTC, valued at over US$2.16 billion at current market levels. Under the joint venture (JV), VCI Global will hold a 70% equity stake and lead commercialization and infrastructure management, while its digital asset partner retains full custody and control of the BTC reserves. Together,...

Midland Commences an Exploration Program for Copper-Gold-Molybdenum-Silver Occurrences on the Saruman Project

Written by Customer Service on August 19, 2025. Posted in Mergers And Acquisitions.

Figure 1Saruman-LocationFigure 2Saruman-Lake Bottom Copper AnomaliesFigure 3Saruman-SamplingFigure 4Saruman-Outcrops PhotosMONTREAL, Aug. 19, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the start of an exploration program to follow up on the 2024 copper-gold-molybdenum-silver (Cu-Au-Mo-Ag) occurrences identified on its Saruman project. Located in the Eeyou Istchee James Bay region, approximately 75 kilometres north of the Troilus Gold Corp. copper-gold (Cu-Au) project, the Saruman project was acquired by map designation in November 2023, is wholly owned by Midland and consists of 121 claims covering a surface area of 64 square kilometres. 2024 Highlights:Strong copper anomalies particularly concentrated within an area of 5 by 3 kilometres,...

Universal Safety Products, Inc. Reports First-Quarter Results

Written by Customer Service on August 19, 2025. Posted in Earnings Releases And Operating Results.

OWINGS MILLS, Md., Aug. 19, 2025 (GLOBE NEWSWIRE) — Universal Safety Products, Inc. (NYSE American: UUU) today announced results for its fiscal quarter ended June 30, 2025. The Company reported sales of $3,824,247 for the quarter ending June 30, 2025, versus $4,598,516 for the comparable period of last year. The Company reported net income of $1,810,321 or $0.78 per basic and diluted share, compared to a net loss of $(442,206), or $(0.19) per basic and diluted share, for the same period last year. Included in the June 30, 2025 results was a gain of $2,820,668 from the sale of our smoke and carbon monoxide alarm segment. Harvey Grossblatt – President and CEO said: “Sales were lower in the current quarter since we sold our smoke alarm segment in May 2025. Sales were further negatively impacted by the increased import tariffs...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals